New registry to monitor fabry drug safety in pregnancy
NCT ID NCT06941025
First seen Apr 05, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study is a worldwide registry that will follow about 10 women with Fabry disease who take the medication pegunigalsidase alfa during pregnancy or while breastfeeding. Researchers will track the health of both mothers and their babies for up to one year after birth. The goal is to better understand any risks or outcomes related to using this drug during these periods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No physical study sites - Decentralized, web-based registry
RECRUITINGWashington D.C., District of Columbia, 20001, United States
-
No physical study sites - Decentralized, web-based registry
RECRUITINGBerlin, Germany
-
No physical study sites - Decentralized, web-based registry
RECRUITINGRome, Italy
-
No physical study sites - Decentralized, web-based registry
RECRUITINGMadrid, Spain
-
No physical study sites - Decentralized, web-based registry
NOT_YET_RECRUITINGLondon, United Kingdom
Conditions
Explore the condition pages connected to this study.